Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
40 participants
INTERVENTIONAL
2010-03-31
2012-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gabapentin and Neural Mobilization Pain Reduction Effect Compared to Only Gabapentine
NCT06778798
Oral Gabapentin and Median Nerve Mobilization in the Treatment of Carpal Tunnel Syndrome
NCT04285281
Pain Reduction and Changes in Upper Limb Function Produced by Different Treatments in Carpal Tunnel Syndrome
NCT04025203
The Effect Of An Anesthetic Procedure On Post Operative Pain Management In Carpal Tunnel Release
NCT03729375
Evaluation by Clinical and Hand Ultrasound in Carpal Tunnel Syndrome
NCT07134361
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Anesthesia was regional intravenous block. Postoperative analgesia when needed was with acetaminophen. If needed was administered codeine. The evaluation of neuropathic pain was made by DN4 questionnaire. Pain intensity was assessed by numeric scale at block and after 30min, 1h, 2h, 2wk, 4wk, 6m. It was noted the duration of analgesia, and the amount of acetaminophen and codeine.
The statistical program used for analysis of the results was the Instat Graph
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
preoperative gabapentine,
Gabapentine
Gabapentine
Gabapentine 600 mg 01 dose
sugar pill
Placebo group
Sugar pill
Sugar pill 01 dose
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gabapentine
Gabapentine 600 mg 01 dose
Sugar pill
Sugar pill 01 dose
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal University of São Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rioko Kimiko Sakata
Pain Clinic Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rioko K Sakata, PhD
Role: STUDY_DIRECTOR
Universidade Federal de São Paulo
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CEP 0223/09
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.